UCP2 and cholangiocarcinoma: However, in post-resection in situ livers, both UCP2 and 4-HNE immunoscore levels were significantly elevated in cholangiocarcinoma patients compared to all other indications combined (190.0 vs. 151.9; p = 0.021 and 163.3 vs. 119.9; p = 0.005).